$159.5 million of cash, cash equivalents and marketable securities as of March 31, 2025 The company is exploring the potential for continued development of its norovirus vaccine candidates ...

New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a ...

Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on ...

As the mercury drops and we start reaching for our scarves and slippers, there’s another reason to brace ourselves this ...

The awards were granted under the Vaxart, Inc. 2024 Inducement Award Plan as an employment “inducement award” pursuant to ...

New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a ...

New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a delivery system for ...

Vaxart gets BARDA nod to begin dosing in 10,000-participant portion of phase 2b Covid-19 clinical trial: South San Francisco, California Saturday, May 17, 2025, 18:00 Hrs [IST] Va ...

Australians are being warned to prepare for a triple virus surge this winter, with COVID-19, influenza, and RSV already spreading rapidly, and are urged to get vaccinated before the end of May.